Pharmacotherapy of neurological complications after cardiac surgery

Komarov R.N.; Vinokurov I.A.

doi:https://doi.org/10.17116/kardio20169120-24

Close metadata

Recommended articles:

Contemporary aspects of brain protection in aortic arch surgery. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(2):164-173

Risk factors of severe chylothorax after cardiac surgery in children. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(5):526-533

Cognitive impairment after major surgical operations. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):74-80

Diseases of the upper gastrointestinal tract in pregnancy: what should the gastroenterologist consider?. Russian Journal of Evidence-Based Gastroenterology. 2025;(2):30-42

Preoperative levosimendan inhalation in a patient with mitral regurgitation and severe pulmonary hypertension. Russian Journal of Anesthesiology and Reanimatology. 2025;(4):95-95

Attention deficit hyperactivity disorder: pharmacotherapy in special situations. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(10):59-65

Psychotherapeutic component in the treatment of acute and prevention of chronic postoperative pain. Problems of Balneology, Physiotherapy and Exercise Therapy. 2025;(5-2):44-49

Abstract:

Keywords:

pharmacotherapy

neurological complications

cardiac surgery

Authors:

Komarov R.N.

Clinic for Aortic and Cardiovascular Surgery, I.M. Sechenov First Moscow State Medical University

ORCID: 0000-0002-3904-6415

Vinokurov I.A.

FGBU "Rossiĭskiĭ nauchnyĭ tsentr khirurgii im. akad. B.V. Petrovskogo" RAMN, Moskva

Close metadata

References:

Bokeriya L.А., Gudkova R.G. Serdechno-sosudistaya khirurgiya - 2013. Bolezni i vrozhdennye anomalii sistemy krovoobrashheniya [Cardiovascular Surgery - 2013. Diseases and congenital malformations of the circulatory system]. M.: NTSSSKH im. А.N. Bakuleva. 2014;220. (in Russian)
Eliseev E.V., Nedorostkova T.YU., Rumyantseva S.А., Аfanas'ev V.V. Opyt korrektsii oteka mozga pri tserebral'nykh infarktakh [Experience of cerebral edema correction in cerebral infarction]. Nevrologiya, nejropsikhiatriya, psikhosomatika. 2012;3:65-69. (in Russian)
Nikonov V.V., Savitskaya I.B. Novye vozmozhnosti kombinirovannoj nejroprotektsii v lechenii ishemicheskogo insul'ta [New opportunities of combined neuroprotection in ischemic stroke management]. Nejronauki: teoretichni i praktichni aspekti. 2007;3(1-2):85-88. (in Russian)
Rumyantseva S.А., Stupin V.А., Аfanas'ev V.V., Fedin А.I., Silina E.V. Kriticheskie sostoyaniya v klinicheskoj praktike [Critical conditions in clinical practice]. M.: MIG «Meditsinskaya kniga». 2011;752. (in Russian)
Spasenko P.V. Lechenie bol'nykh s tyazheloj cherepno-mozgovoj travmoj s primeneniem L-lizina ehstsinata [Treatment of patients with severe traumatic brain injury using L-lysine aescinat]. Ukrainskij nejrokhirurgicheskij zhurnal. 2003;4:33-41. (in Russian)
Arrowsmith JE, Harrison MJ, Newman SP, Stygall J, Timberlake N, Pugsley WB. Neuroprotection of the brain during cardiopulmonary bypass: a randomized trial of remacemide during coronary artery bypass in 171 patients. Stroke. 1998;29(11):2357-2362.
Baumgartner WA. Neurocognitive changes after coronary bypass surgery. Circulation. 2007;116(17):1879-1881.
Baumgartner WА, Redmond M, Brock M, Tseng E, Blue ME, Troncoso JC, Johnston MV. Pathophysiology of cerebral injury and future management. J Card Surg. 1997;12(2 Suppl): 300-311.
Bendszus M, Reents W, Franke D, Mullges W, Babin-Ebell J, Koltzenburg M, Warmuth-Metz M, Solymosi L. Brain damage after coronary artery bypass grafting. Arch Neurol. 2002;59(7):1090- 1095.
Chumas PD, Del Bigio MR, Drake JM, Tuor UI. A comparison of the protective effect of dexamethasone to other potential prophylactic agents in a neonatal rat model of cerebral hypoxia-ischemia. J Neurosurg. 1993;79(3):414-420.
Dewhurst AT, Moore SJ, Liban JB. Pharmacological agents as cerebral protectants during deep hypothermic circulatory arrest in adult thoracic aortic surgery. Anesthesia. 2002;57(10):1016-1021.
Endres M, Wang ZQ, Namura S, Waeber C, Moskowitz MA. Ischemic brain injury is mediated by the activation of poly(ADPribose) polymerase. J Cereb Blood Flow Metab. 1997;17(11):1143- 1151.
Floyd TF, Shah PN, Price CC, Harris F, Ratcliffe SJ, Acker MA, Bavaria JE, Rahmouni H, Kuersten B, Wiegers S, McGarvey ML, Woo JY, Pochettino AA, Melhem ER. Clinically silent cerebral ischemic events after cardiac surgery: their incidence, regional vascular occurrence, and procedural dependence. Ann Thorac Surg. 2006;81(6):2160-2166.
Griepp E, Griepp R. Cerebral consequences of hypothermic circulatory arrest in adults. J Card Surg. 1992;7(2):134- 155.
Hall R, Murdoch J. Brain protection: physiological and pharmacological considerations. Part II: the pharmacology of brain protection. Can J Anaesth. 1990;37(7):762-777.
Keyrouz S, Diringer M. Clinical review: prevention and therapy of vasospasm in subarachnoid hemorrhage. Crit Care. 2007;11(4):220- 237.
Langley SM, Chai PJ, Jaggers JJ, Ungerleider RM. Preoperative high dose methylprednisolone attenuates the cerebral response to deep hypothermic circulatory arrest. Eur J Cardiothorac Surg. 2000;17(3):279-286.
Legault C, Furberg CD, Wagenknecht LE, Rogers AT, Stump DA, Coker L, Troost BT, Hammon JW. Nimodipine neuroprotection in cardiac valve replacement. Stroke. 1996;27(4):593-598.
Li M, Lu C, Zhang L, Zhang J, Du Y, Duan S, Wang T, Fu F. Oral Administration of Escin Inhibits Acute Inflammation and Reduces Intestinal Mucosal Injury in Animal Models. Evid Based Complement Alternat Med. 2015;2015:503617.
Mandir AS, Poitras MF, Berliner AR, Herring WJ, Guastella DB, Feldman A, Poirier GG, Wang ZQ, Dawson TM, Dawson VL. NMDA but not non-NMDA excitotoxicity is mediated by Poly(ADP-ribose) polymerase. J Neurosci. 2000;20(21):8005- 8011.
Mizuno T, Kamiyama H, Mizuno M, Mizukoshi T, Shinoda A, Harada K, Uchida S, Lee JS, Kasuya A, Sawada T, Uechi M. Plasma cytokine levels in dogs undergoing cardiopulmonary bypass. Res Vet Sci. 2015;101:99-105.
Montoliu C, Llansola M, Monfort P, Corbalan R, Fernandez- Marticorena I, Hernandez-Viadel ML, Felipo V. Role of nitric oxide and cyclic GMP in glutamate-induced neuronal death. Neurotox Res. 2001;3(2):179-188.
Muir K, Lees K. Clinical experience with excitatory amino acid antagonist drugs. Stroke. 1995;26(3):503-513.
Nussmeier N, Arlund C, Slogoff S. Neuropsychiatric com- plications after cardiopulmonary bypass: cerebral protection by a barbiturate. Anesthesiology. 1985;64(2):165-170.
Olney J. Neurotoxicity of excitatory amino acids. In: McGeer EG, McGeer PL (eds.). Kainic acid as a tool in neurobiology. New York: Raven. 1978;95.
Pieper AA, Blackshaw S, Clements EE, Brat DJ, Krug DK, White AJ, Pinto-Garcia P, Favit A, Conover JR, Snyder SH, Verma A. Poly(ADP-ribosyl)ation basally activated by DNA strand breaks reflects glutamate-nitric oxide neurotransmission. Proc Natl Acad Sci USA. 2000;97(4):1845-1850.
Redmond J, Gillinov A, Zehr K, Blue ME, Troncoso JC, Reitz BA, Cameron DE, Johnston MV, Baumgartner WA. Glutamate excitotoxicity: a mechanism of neurologic injury associated with hypothermic circulatory arrest. J Thorac Cardiovasc Surg. 1994;107(3):776-786.
Redmond JM, Greene PS, Goldsborough MA, Cameron DE, Stuart RS, Sussman MS, Watkins LJr, Laschinger JC, McKhann GM, Johnston MV, Baumgartner WA. Neurologic injury in cardiac surgical patients with a history of stroke. Ann Thorac Surg. 1996;61(1):42-47.
Reparile AY. A selective anti-oedematous and anti-inflammatory agent. Koln. 1989;34.
Roach GW, Kanchuger M, Mangano CM, Newman M, Nussmeier N, Wolman R, Aggarwal A, Marschall K, Graham SH, Ley C. Adverse cerebral outcomes after coronary bypass surgery. Multicenter Study of Perioperative Ischemia Research Group and the Ischemia Research and Education Foundation Investigators. N Engl J Med. 1996;335(25):1857-1863.
Rothman SM, Olney JW. Glutamate and the pathophysiology of hypoxic–ischemic brain damage. Ann Neurol. 1986;19(2):105-111.
Rudolph JL, Jones RN, Rasmussen LS, Silverstein JH, Inouye SK, Marcantonio ER. Independent vascular and cognitive risk factors for postoperative delirium. Am J Med. 2007;120(9):807-813.
Shapiro H. Barbiturates in brain ischemia. Br J Anesthesia. 1985;57(1):82-95.
Shum-Tim D, Tchervenkov C, Jamal A, Nimeh T, Luo CY, Chedrawy E, Laliberte E, Philip A, Rose CP, Lavoie J. Systemic steroid pretreatment improves cerebral protection after circulatory arrest. Ann Thorac Surg. 2001;72(5):1465- 1472.
Tseng EE, Brock MV, Lange MS, Troncoso JC, Lowenstein CJ, Blue ME, Johnston MV, Baumgartner WA. Nitric oxide mediates neurologic injury after hypothermic circulatory arrest. Ann Thorac Surg. 1999;67(1):65-71.
Wang H, Zhang L, Jiang N, Wang Z, Chong Y, Fu F. Anti-inflammatory effects of escin are correlated with the glucocorticoid receptor/ NF-κB signaling pathway, but not the COX/PGF2α signaling pathway. Exp Ther Med. 2013;6(2):419-442.
Won SJ, Kim DY, Gwag BJ. Cellular and molecular pathways of ischemic neuronal death. J Biochem Mol Biol. 2002;35(1):67-86.
Wu XJ, Cui XY, Tian LT, Gao F, Guan X, Gu JK. Pharmacokinetics of escin Ia in rats after intravenous administration. J Ethnopharmacol. 2014;156:125-129.
Zaidan J, Klochany A, Martin W, Ziegler JS, Harless DM, Andrews RB. Effect of thiopental on neurologic outcome following coronary artery bypass grafting. Anesthesiology. 1991;74(3):406- 411.
Zhang Y, Bhavnani BR. Glutamate-induced apoptosis in neuronal cells is mediated via caspase-dependent and independent mechanisms involving calpain and caspase-3 proteases as well as apoptosis inducing factor (AIF) and this process is inhibited by equine estrogens. BMC Neurosci. 2006;7:49.